“High Tumor Burden” in Metastatic Non-Small Cell Lung Cancer: Defining the Concept

Autor: Higuera Gómez O, Moreno Paul A, Ortega Granados AL, Ros Martínez S, Pérez Parente D, Ruiz Gracia P, Sáenz Cuervo-Arango L, Vilà L

Publikováno v: Cancer Management and Research, Vol Volume 13, Pp 4665-4670 (2021)

Oliver Higuera Gómez,1 Amaia Moreno Paul,2 Ana Laura Ortega Granados,3 Silverio Ros Martínez,4 Diego Pérez Parente,5 Pedro Ruiz Gracia,5 Lucía Sáenz Cuervo-Arango,6 Laia Vilà7 1Department of Medical Oncology, La Paz University Hospital, Madrid,

Externí odkaz: https://doaj.org/article/6af1af3936cb46449a6159c5cc93acda

EP11.03-13 Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study

Autor: Álvarez, R., Carcereny, E., Padilla, A., Rodríguez García, J.M., Córdoba, J.F., Esteban, E., Aguado, C., Garde, J., Moreno Vega, A., Ávila Andrade, C., Sereno, M., Sánchez-Hernández, A., López-Brea, M., Massuti, B., Martí Blanco, C., Campayo, M., Arnáiz, P., Pérez Parente, D., Fajardo, C.A., Ramos, I.

Publikováno v: In Journal of Thoracic Oncology November 2023 18(11) Supplement:S625-S626

Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database

Autor: Campos-Balea B, de Castro Carpeño J, Massutí B, Vicente-Baz D, Pérez Parente D, Ruiz-Gracia P, Crama L, Cobo Dols M

Publikováno v: Thoracic Cancer
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

BACKGROUND: Lung adenocarcinoma (ADC) is the main cause of death related to lung cancer. The aim of this study was to identify poor prognostic factors for overall survival (OS) in patients with stage IV lung ADC in real-world clinical practice. METHO

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::d0be8f80fdeb624c0637c8fa27ac6bf0
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=6884

EP08.01-065 Prevalence of Non-driver Mutations and Characterization of Patients with Advanced or Metastatic Non-small Cell Lung Cancer

Autor: Provencio, M., Pérez Parente, D., Hasan, H., Campos Balea, B., Rodríguez Abreu, D., López Brea Piqueras, M., Olson, S., Pal, N., Wilkinson, S., de Oro-Pulido, F., Ruiz Gracia, P., Cobo Dols, M.

Publikováno v: In Journal of Thoracic Oncology September 2022 17(9) Supplement:S370-S371

1064P Genomic characterization of first line advanced or metastatic non-small cell lung cancer (aNSCLC) patients (pts) subgroups associated with good/bad prognosis

Autor: Provencio Pulla, M., Perez Parente, D., Campos Balea, B., Rodriguez Abreu, D., Hasan, H., Olson, S., Pal, N., Wilkinson, S., De Oro Pulido, F., Ruiz Gracia, P., Cobo Dols, M.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S1040-S1041